PharmNexus is an international, peer-reviewed, open-access journal in pharmaceutical sciences. The journal provides a rigorous platform for high-quality research and places particular emphasis on interdisciplinary studies linking basic research, technological innovation, and clinical application.

This journal contains seven sections:

Pharmacology and new targets of disease: This section focuses on the mechanisms of drug action, pharmacological evaluation, dosage form design, and the discovery of new targets for human diseases through related technologies.

Medicinal Chemistry and Pharmaceutical Analysis: This section covers the discovery, design, synthesis, characterization, and analysis of pharmaceutical compounds, as well as analytical methods for drug quality, safety, and efficacy evaluation.

Natural Products and Pharmacognosy: This section focuses on the identification, extraction, characterization, and pharmacological investigation of natural products, including studies related to medicinal plants, traditional medicines, and bioactive compounds.

Biologics: This section covers the discovery, development, characterization, production, and evaluation of biologically derived therapeutics, including proteins, antibodies, vaccines, and related products.

Advanced Drug Delivery Systems and Their Applications in Human Medicine: This section focuses on the design, optimization, and biomedical application of advanced delivery systems for improving drug targeting, bioavailability, therapeutic efficacy, and patient outcomes.

Artificial Intelligence and Big Data in Pharmaceutical Sciences: This section covers the development and application of computational models, data-driven methods, and digital tools for drug discovery, pharmaceutical research, and translational studies.

Multi-omics Methods and Applications in Pharmaceutical Sciences: This section focuses on omics-based methods, analytical workflows, and integrative strategies for understanding drug action, disease mechanisms, biomarkers, and therapeutic responses.